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1. Introduction
A patient with implanted cardiac pacemaker may 
be a candidate for BNCT. Radiation may cause 
permanent damage or temporary malfunctions on 
semiconductor materials found in pacemakers. 
For the safe pacemaker functioning during photon 
radiotherapy, it has been suggested, that the 
pacemaker should not be placed in the direct therapy 
beam and the cumulative dose to pacemaker is 
limited to 2 Gy (Marbach et al. 1994). Wide photon 
dose rage (0.5-40 Gy) has reported to affect pace-
maker function (Tondato et al. 2009, Oshiro et al. 
2008). Permanent damage can occur to a pacemaker 
after exposure to 10 Gy in a photon beam irradiation 
(Last 1998, Marbach et al 1994). Maximum tolerable 
cumulative radia tion dose for safe operation of 
pacemakers depends highly on pacemaker type and 
model as well as on the dose rate (Mouton et al. 
2002). Modern pacemakers with complimentary 
metal oxide semiconductor (CMOS) cir cuits are 
more radiosensitive than older pace makers with 
nonprogrammable bipolar semi conductors (Solan 
et al. 2004).  For the modern pacemakers in a high-
energy photon beam irradiation, a maximum dose 
rate of 12 Gy/h rejecting direct irradiation of the 
pace maker is recommended for the safe operation 
of pacemakers, while no malfunction has been 
observed with the dose rates lower than 3 Gy/h 
(Mouton et al. 2002). Usual recommendation 
of the pacemaker manufacturers is that the total 
cumulative dose should never exceed 5 Gy. Protons 
and neutrons with densely ionizing tracks are 
more likely to cause damage than photons. Minor 
pacemaker changes have been detected during 
proton beam therapy caused by scattered neutrons 
(Oshiro et al. 2008). Catastrophic pacemaker 
malfunction has been reported during fast neutron 
therapy at a dose of only 0.9 Gy (Raitt et al. 1994). 
The pacemaker was not perma nently damaged due 
to 0.9 Gy fast neutron dose, but its programming 
code was signifi  cantly corrupted. Interference of a 
neutron beam used for BNCT with a pacemaker has 
not yet been reported in the literature. A phantom 
study was performed to evaluate im pact of an 
epithermal neutron beam irradiation on the cardiac 
pacemaker function.
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2. Materials and Methods
Neutron fl uence and photon dose at typical pacemaker 
location was calculated with the SERA treatment 
planning system for a neck area tumor patient. At 
the pacemaker located at 10 cm distance from the 
beam aperture edge at about 0.5 cm depth under skin 
maximum fl uence rate of thermal (E < 0.414 eV) neu-
trons was 1.8 × 108 neutrons/cm2/s, epithermal (0.414 
eV < E < 9.12 keV) neutrons 1.8 × 108 neutrons/cm2/s 
and fast neutrons (E > 9.12 keV) 8.2 × 106 neutrons/
cm2/s. The maximum fast neutron dose rate calculated 
in soft tissue (10.1 w-% of hydrogen and 2.6 w-% of 
nitro gen) was 0.1 Gy/h and maximum thermal neutron 
dose (due to nitrogen capture) 0.3 Gy/h. Maximum 
photon dose rate at the pace maker location was 1.3 
Gy/h. Approximately similar irradiation conditions 
were reproduced in a water phantom. A large (51 
cm ×51 cm ×47 cm) cubical water phantom with 1 
cm thick PMMA walls and 0.5 cm thick beam side 
window (Ø 30 cm) was applied. 
Two cardiac pacemaker models (Verity ADx XL 
DR 5356 and Zephyr DR 5820) of St Jude Medical 
were tested in the FiR 1 epi thermal neutron beam. 
Both models are of modern type using CMOS 
circuitry. The pacemakers were attached on the 0.5 
cm thick phantom inner wall at 9 cm (Zephyr) and 
13 cm (Verity) off the 14 cm diameter beam central 
axis (Figure 1). The phantom was placed at the 10 
cm distance from the beam aperture plane.
The predicted neutron fl uences as well as the total 
neutron and photon doses in water calculated using 
MCNP5 at the pacemaker locations are shown in 
table I. Tally F4 was used to determine the fl uences 
and tally F6 the doses. Pacemaker structures were 
not modeled, since exact elemental composition 
and structures inside the pacemakers are com pany 
confi dential information and thus not available from 
the manufacturer. Thus pace makers were modeled 
as 0.5 cm thick cylindri cal water discs with 1.5 cm 
radius. In order to verify the MCNP5 calculations, the 
neutron fl uence was determined at the pacemaker lo-
cation using diluted MnAl and AuAl activation foils 
with 1 w-% of manganese and gold. The reaction 
rates were calculated with MCNP5 using 0.1 cm thick 
cylindrical tally volumes of 0.5 cm radius and the F4 
tally with the tally multiplier card scoring the total 
number of (n,γ) reactions in manganese and gold.
The photon dose was measured using a Mg(Ar) 
ionization chamber of Exradin. The ionization 
chamber was placed behind and between the 
pacemakers touching them, at 11 cm off the beam 
central axis as shown in ﬁ g ure 1. At that location, 
the chamber measures dose at about 2 cm behind 
the pacemakers.  The pacemakers were irradiated 
for an hour, which is about a typical duration of 
the two-ﬁ eld neck tumor BNCT treatment at FiR 1. 
The pacemakers were interrogated be fore and after 
irradiation, when the pulse vol tages and intervals 
generated by the pace makers were measured. Also, 
pacemaker neutron activation itself was measured. 
3. Results and Discussion
Severe malfunction was detected in case of both 
pacemakers after the irradiation. Verity went into 
‘Back-Up mode VVI’ due to multi ple unexpected 
memory changes in micro processor, meaning that 
the backup program had turned safe pacing rate 
on. Zephyr lost it’s ID bit and cleared the registry 
due to many severe bit ﬂ ips. It was impossible to 
interro gate the device after the irradiation. The both 
pacemakers got activated due to several nuclides 
listed in table II. Most of these nuclides are also β 
active. The measured dose rate on the pacemaker 
sur face immediately after the irra diation was 400 
Figure 1. Exradin Mg(Ar) ionization chamber,  activation 
foils and the pacemakers inside the water phantom placed at 
10 cm dis tance from the 14 cm circular FiR 1 beam aperture.
Distance
from beam 
axis
cm
D
g
Gy
D
neutron
Gy
Φ
thermal
×1012 
neutrons/cm2
Φ
epithermal
×1012 
neutrons/cm2
Φ
fast
×1012 
neutrons/cm2
Zephyr 9 2.0±0.2% 0.2±0.8% 1.6±0.1% 1.1±0.1% 0.02±0.6%
Verity 13 1.2±0.3% 0.1±1.3% 0.8±0.2% 0.5±0.2% 0.009±1.0%
Table I. Total thermal, epithermal and fast neutron ﬂ uences (Φ
thermal
, Φ
epithermal
 and Φ
fast
) and total absorbed neutron (D
neutron
) and 
photon doses (D
γ
) calculated with the MCNP5 at the Zephyr and Verity pacemaker locations in the water phantom for one hour 
irradiation.
µSv/h for the Zephyr and 150 µSv/h for the Verity. 
Calculated 55Mn(n,γ) and 197Au(n,γ) reaction rates 
agreed with the measurements within 13% and 9% 
respectively. The measured photon dose was 2.6 
Gy and the calculated using MCNP5 1.9 Gy at the 
measurement location. The calculated photon doses 
at the pacemaker locations were 2.0 Gy and 1.2 Gy. If 
the actual photon dose would had been 33% greater, 
as may be suggested based on the measurement, the 
actual photon doses at the pacemaker sites would had 
been 2.7 Gy and 1.6 Gy, with corresponding dose 
rates of 3.0 and 1.8 Gy/h. Permanent pacemaker 
malfunctions has been reported at a dose below 2 Gy 
in a photon beam only if the dose is delivered with 
a dose rate above 30 Gy/h (Mouton et al. 2002). In 
the same study, none of the 96 irradiated pacemakers 
failed at a dose rate lower than 12 Gy/h. At 18 MeV 
photon beam energy, neutrons may play partial role 
in the radiation damage. At lower (6 MV-10 MV) 
photon beam energies, permanent pacemaker failure 
has not been detected at cumulative doses below 10 
Gy (Last 1998).
Absorbed neutron dose in the pacemaker is material 
dependent and thus, exact neutron dose esti mation is 
difﬁ cult. In this study, we have reported the absorbed 
dose calculated in water at the pacemaker location. 
The calculated epithermal and thermal neutron 
fl uence rate at the pacemaker locations was almost 
100 times that of fast neutron fl uence. The neutron 
fl uence spectra at the pacemaker locations are shown 
in fi gure 2. 
mainly due to neutron activation of the pacemaker 
struc tures, since the β-active radionuclides may cause 
changes in semiconductors inside the device.
4. Conclusions
These results suggest that already low neutron dose 
from epithermal neutron irradiation causes pacemaker 
malfunction, and thus BNCT should be administrated 
only after removal and replacement of the pacemaker 
from the vicinity of the tumor. In addition, pacemaker 
components get activated in the BNCT beam 
causing additional radiation dose to patient and risk 
of unexpected memory changes in the pacemaker’s 
microprocessor that may cause malfunction to the 
device also after BNCT irradiation.
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Figure 2. Neutron fl uence rate calculated with MCNP5 at 
the Verity and Zephyr pacemaker locations in the phantom. 
Nuclide T
1/2
E
g
 (keV)
128I 25.0 min 442.9
198Au 2.695 d 411.8
187W 23.72 h 685.8
56Mn 2.58 h 846.8
194Ir 19.28 h 328.5
60Co 5.3 y 1173.2, 1332.5
51Cr 27.7 d 320.1
192Ir 73.8 d 316.5
182Ta 114.7 d 67.8, 1121.3
201Tl 3.0 d 70.8
187W 24 h 685.8
38Cl 37.2 min 2167.5
The calculated total neutron doses (0.2 Gy and 0.1 
Gy) to the pacemakers are substantially lower than 
the fast neutron dose (0.9 Gy) reported to cause 
pacemaker mal function, not permanent damage. Also, 
deter mined cumulative photon dose at the Zephyr 
pacemaker site is substantially lower (2.7 Gy) than 
the photon doses reported to cause per manent failure 
(dose limit 10 Gy) at the simi lar dose rate level. We 
suggest that the ob served pacemaker malfunction is 
Table II. Major neutron activated radionuclides detected 
using a HPGE gamma spectrometer after pacemaker ir-
radiation, half-lives (T
1/2
) and energies of the principal 
gammas (Eγ).
